Morroniside ameliorates inflammatory skeletal muscle atrophy via inhibiting canonical and non-canonical NF-?B and regulating protein synthesis/degradation. (2022)

First Author: Yi X

Attributed to: UK Biobank (core renewal) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2022.1056460

PubMed Identifier: 36618945

Publication URI: http://europepmc.org/abstract/MED/36618945

Type: Journal Article/Review

Volume: 13

Parent Publication: Frontiers in pharmacology

ISSN: 1663-9812